RU2387448C2 - Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии - Google Patents

Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии Download PDF

Info

Publication number
RU2387448C2
RU2387448C2 RU2006140277/14A RU2006140277A RU2387448C2 RU 2387448 C2 RU2387448 C2 RU 2387448C2 RU 2006140277/14 A RU2006140277/14 A RU 2006140277/14A RU 2006140277 A RU2006140277 A RU 2006140277A RU 2387448 C2 RU2387448 C2 RU 2387448C2
Authority
RU
Russia
Prior art keywords
ethyl ester
acid
eicosanpentanoic
docosanhexanoic
acid ethyl
Prior art date
Application number
RU2006140277/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2006140277A (ru
Inventor
Сес-Нико ВЕРБОМ (DE)
Сес-Нико ВЕРБОМ
Райнер ЁЛЬЦЕ (DE)
Райнер ЁЛЬЦЕ
Original Assignee
Зольвай Фармасьютиклз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зольвай Фармасьютиклз Гмбх filed Critical Зольвай Фармасьютиклз Гмбх
Publication of RU2006140277A publication Critical patent/RU2006140277A/ru
Application granted granted Critical
Publication of RU2387448C2 publication Critical patent/RU2387448C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2006140277/14A 2004-04-16 2005-04-15 Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии RU2387448C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101578.5 2004-04-16
EP04101578 2004-04-16

Publications (2)

Publication Number Publication Date
RU2006140277A RU2006140277A (ru) 2008-05-27
RU2387448C2 true RU2387448C2 (ru) 2010-04-27

Family

ID=34928968

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006140277/14A RU2387448C2 (ru) 2004-04-16 2005-04-15 Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии

Country Status (12)

Country Link
EP (1) EP1765319A1 (https=)
JP (1) JP2007532605A (https=)
CN (1) CN1942180A (https=)
AU (1) AU2005244483B2 (https=)
BR (1) BRPI0509878A (https=)
CA (1) CA2504280A1 (https=)
IL (1) IL178300A0 (https=)
MX (1) MX291518B (https=)
RU (1) RU2387448C2 (https=)
UA (1) UA94693C2 (https=)
WO (1) WO2005110393A1 (https=)
ZA (1) ZA200607794B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2421909A (en) * 2004-12-23 2006-07-12 Laxdale Ltd Pharmaceutical compositions comprising EPA and methods of use
ITMI20100961A1 (it) * 2010-05-27 2011-11-28 Erredue Spa Miscele ricche in esteri di acidi grassi omega-3, loro composizioni e loro processo di preparazione

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2362271A1 (en) * 1999-02-17 2000-08-24 Pharmacia & Upjohn S.P.A. Essential fatty acids in the prevention of cardiovascular events
RU2001134300A (ru) * 1999-07-14 2003-08-27 Лэксдейл Лимитед (GB) Фармацевтические и пищевые композиции, содержащие незаменимые жирные кислоты и гомоцистеин-понижающие агенты

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048788A1 (en) * 1997-04-29 1998-11-05 Scotia Holdings Plc Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
ATE291910T1 (de) * 2001-05-30 2005-04-15 Laxdale Ltd Verwendung von coenzym q (ubiquinone) und eikosapentaensäure (epa) für die behandlung von non-hodgkin's lymphoma und psychiatrischen oder neurologischen erkrankungen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2362271A1 (en) * 1999-02-17 2000-08-24 Pharmacia & Upjohn S.P.A. Essential fatty acids in the prevention of cardiovascular events
RU2001134300A (ru) * 1999-07-14 2003-08-27 Лэксдейл Лимитед (GB) Фармацевтические и пищевые композиции, содержащие незаменимые жирные кислоты и гомоцистеин-понижающие агенты

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
СУМАРОКОВ А.В. и др. Клиническая кардиология. - М.: «Универсум Паблишинг», 1995, с.6, 13, 65-70. McLENNAN P. et al. "The cardiovascular protective role of docosahexaenoic acid". Eur J Pharmacol. 1996 Apr 4; 300 (1-2): 83-9, реферат. TURNER N et al. "Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism". Naturwissenscaften 10.10.2003, p.p.521-523. *

Also Published As

Publication number Publication date
UA94693C2 (ru) 2011-06-10
CN1942180A (zh) 2007-04-04
AU2005244483A1 (en) 2005-11-24
CA2504280A1 (en) 2005-10-16
MX291518B (es) 2011-10-31
JP2007532605A (ja) 2007-11-15
RU2006140277A (ru) 2008-05-27
ZA200607794B (en) 2008-05-28
BRPI0509878A (pt) 2007-10-16
WO2005110393A1 (en) 2005-11-24
IL178300A0 (en) 2007-02-11
AU2005244483B2 (en) 2011-06-09
MXPA06011940A (es) 2006-12-15
EP1765319A1 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
JP5441287B2 (ja) 心血管事象を予防するための必須脂肪酸
JP5827784B2 (ja) ビタミンｋ２を含む医薬及び栄養補助製品
ES2576578T3 (es) Composición de ácidos grasos n-3 que presentan una concentración elevada de EPA y/o DHA y que contiene ácidos grasos n-6
US4874603A (en) Use of vitamin E for normalization of blood coagulation during therapy with high unsaturated fatty acids of omega-3 type
MXPA05009432A (es) Uso de acidos grasos omega-3 en el tratamiento de pacientes diabeticos.
UA78693C2 (en) Use of eicosapentaenoic acid ethyl ester and docosahexaenoic acid ethyl ester for treating heart failure
IL91275A (en) Fatty acid composition containing a mixture of (all-Z)-5, 8, 11, 14, 17-eicosapentaenoic acid and (all-Z)-4, 7, 10, 13, 16, 19-docosahexaenoic acid for treatment and prophylaxis of multiple risk factors for cardiovascular diseases
EP0321128A1 (en) Fatty acid compositions
EP1474125A1 (en) The use of omega-3 polyunsaturated acids ethyl esters in patients suffering from heart failure
WO1995017889A1 (en) Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
US20080166419A1 (en) Krill oil compositions
RU2387448C2 (ru) Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии
US8114906B2 (en) Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease
US9808437B2 (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
US11039997B2 (en) Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
US10517838B2 (en) Compositions against alkyl-acyl GPC, the derivatives and products thereof
JP2007532605A5 (https=)
JPS59175425A (ja) 脳卒中予防剤
HK1099700A (en) Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease
JPH11239464A (ja) 運動時の危険因子除去能を有する組成物
JPH07233062A (ja) 人工透析患者の皮膚そう痒症治療組成物及び副甲状腺機能亢進症治療組成物
GB2620543A (en) Composition for use
JP2010111662A (ja) 喫煙による循環機能不全の予防／改善または治療剤

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140416